Introduction of new therapeutic drugs in the United States and Great Britain: an international comparison.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use; D000777:Anesthetics; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy; D004232:Diuretics / Q000627:therapeutic use; D004358:Drug Therapy; D064420:Drug-Related Side Effects and Adverse Reactions; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D011188:Potassium / Q000627:therapeutic use; D011600:Psychopharmacology; D012140:Respiratory Tract Diseases / Q000188:drug therapy; D009626:Terminology as Topic; D006113:United Kingdom; D014481:United States; D014944:World Health Organization
D000319:Adrenergic beta-Antagonists; D000700:Analgesics; D000777:Anesthetics; D000890:Anti-Infective Agents; D000970:Antineoplastic Agents; D004232:Diuretics; D005765:Gastrointestinal Agents; D007166:Immunosuppressive Agents; D011188:Potassium